72

million

Heart failure patients globally at every given moment

SCROLL DOWN TO LEARN MORE

Lives that can be saved with proper early detection and warning

millions of fatalities...

billion

Costs that can be saved with proper early detection and warning

US Dollars in hospitalization costs in the US alone

existing solutions

don't cut it

Clinical parameters monitoring

Implantable devices

Non-invasive monitoring

  • Following weight, blood pressure, etc. is not nearly sensitive enough for monitoring of lung congestion in heart failure patients
  • There are no methods for determination of patient’s deterioration at very early stage. Results: prevention of the deterioration and hospitalization is dramatically less efficient hospitalization is impossible
  • No clinical indication for implantation for majority of Heart Failure patients
  • Very expensive device
  • Not suitable for mass monitoring
  • Traditional transthoracic impedance measurement is not sensitive enough to enable prediction
  • Radar Technologies are not supported with enough clinical evidence about efficacy of technology

SOLUTION

Revolutionary non-invasive, early detection device

EDEMA GUARD MONITOR

Registering accurately the most minuscule changes in lung fluid content allowing life-saving pre-emptive treatment at a very early stage

 

seconds

Measurement time while brushing  teeth in the morning

Our device provides immediate results that will be  displayed on the device and sent to the cardiologist when a medication adjustment is required

Monitoring patient’s lung fluid by Edema Guard Monitor.

ABOUT US

We are a group of scientists and business people who strive to make a life-changing impact on patients suffering from heart failure lung edema.

 

With over 15 years of research and development we now have the solution that can literally revolutionize millions of HF patients' lives by enabling them to self-monitor their lung edema state and detect small changes at an even earliest stage.

Relevant scientific interviews and articles

American College of Cardiology (ACC) interview on Impedence HF Trial with Prof. Michael Kleiner Shochat from CARDIOSET

 

2016

Duke Clinical Research Institute interview with Prof. Michael Kleiner Shochat from CARDIOSET

 

 

2016

Clinical Trials Results TV interview  with Prof. Michael Kleiner Shochat from CARDIOSET

 

 

2016

Selected articles

clinical trials

prevention

of heart failure hospitalizations

Potentially saving millions of lives and billions in hospitalization costs

Contact Us.

CardioSet Medical

Noa Building, 2nd floor, 16 Bar Kochba Rd. Bnei Brak 5120149, ISRAEL

Tel. +972-73-7997876

Fax +972-72-7997870

 

Submitting Form...

The server encountered an error.

Form received.

29 01 30 >60% 1500+

PROBLEM

HOME

SOLUTION

ABOUT

CONTACT

1500+
72
01
29
30
>60%
72
01
1500+
>60%
29
30
72
01
1500+
>60%
29
30
72
1500+
>60%
29
01
30